Delivery Order SPE2DB20D2104-SPE2DB25FMXKW
Award Date 8/11/25
Potential Completion Date 8/12/25
Potential Value $4.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at approximately $25K to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg–26 mg tablets (180-count units) on July 30, 2025, with completion targeted for July 31, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the vendor's corporate headquarters location in Conshohocken, Pennsylvania. Entresto is a combination medication used primarily for heart failure...
- The Defense Logistics Agency awarded a $4,198.26 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Entresto 97 mg-103 mg tablets (180-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 21, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. Entresto is a combination medication used primarily for heart failure treatment, reflecting the critical pharmaceutical...
- The Defense Logistics Agency awarded a $4,124.93 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Entresto 49 mg-51 mg on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-competitive delivery order represents a firm fixed price transaction procured without set-aside designation. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Entresto is a combination pharmaceutical product used in heart...
- The Defense Logistics Agency awarded a $74,659.53 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Entresto 24 mg-26 mg tablets (180-count units). This is a firm fixed-price, non-set-aside contract with performance through July 31, 2025, and fulfillment based in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. Entresto is a combination pharmaceutical product commonly prescribed for heart failure management, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $2,989.52 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180-count package) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Entresto is a cardiovascular medication commonly used in the...
- The Defense Logistics Agency awarded a delivery order valued at $11,738.53 to AmerisourceBergen Drug Corp for Entresto 24 mg-26 mg tablets (180-count supply) with a firm fixed price structure. This non-set-aside award was issued on August 4, 2025, with an ultimate completion date of August 5, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Entresto is a combination medication used to treat heart failure, representing the type of critical...
- The Defense Logistics Agency awarded a delivery order valued at $6,072.71 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (60-count units) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Entresto is a combination medication used primarily for heart failure treatment, reflecting...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Entresto 24 mg-26 mg tablets (60 count) under a firm fixed-price contract valued at $16,230.90, with completion expected by July 24, 2025. This non-set-aside competitive award represents a child delivery order executed through AmerisourceBergen's broader federal contract vehicle. The contractor, headquartered in Conshohocken, Pennsylvania, holds a...
- The Defense Logistics Agency awarded a $3,689.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Entresto 24 mg-26 mg tablets (60-count supply) on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-competitive delivery order was placed against AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled at...
- The Defense Logistics Agency awarded a delivery order valued at $4,385.99 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (60-count units). This non-set-aside, firm fixed-price delivery order was awarded on August 4, 2025, with an ultimate completion date of August 5, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Entresto is a combination pharmaceutical product commonly prescribed for heart...